Contract to support Phase II river blindness drug trial Antibiotic drug study for the treatment of the second-most common cause of blindness due to infection
Open Orphan PLC (ORPH.L) Major New Contract Signed
Open Orphan plc (ORPH) a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, is